Carles Besses

3.1k total citations
66 papers, 1.5k citations indexed

About

Carles Besses is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Carles Besses has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Genetics, 32 papers in Hematology and 26 papers in Molecular Biology. Recurrent topics in Carles Besses's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (36 papers), Kruppel-like factors research (19 papers) and Acute Myeloid Leukemia Research (16 papers). Carles Besses is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (36 papers), Kruppel-like factors research (19 papers) and Acute Myeloid Leukemia Research (16 papers). Carles Besses collaborates with scholars based in Spain, United States and United Kingdom. Carles Besses's co-authors include Beatríz Bellosillo, Alberto Álvarez‐Larrán, Adrià Arboix, Juan Carlos Hernández‐Boluda, Anna Angona, Francisco Cervantes, Lourdes Florensa, Montse Gómez, Francisca Ferrer‐Marín and Luz Martínez‐Avilés and has published in prestigious journals such as Blood, PLoS ONE and Cancer Cell.

In The Last Decade

Carles Besses

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carles Besses Spain 22 965 780 680 401 161 66 1.5k
Guillermo Garcia‐Manero United States 24 834 0.9× 532 0.7× 1.3k 1.9× 271 0.7× 248 1.5× 40 1.8k
Alfonso Zaccaria Italy 24 871 0.9× 385 0.5× 1.2k 1.7× 249 0.6× 484 3.0× 116 2.1k
Sybille Albrecht Germany 20 252 0.3× 314 0.4× 611 0.9× 149 0.4× 141 0.9× 35 1.4k
Monica Crugnola Italy 17 330 0.3× 394 0.5× 668 1.0× 117 0.3× 418 2.6× 39 988
Sheng Xiao United States 9 167 0.2× 404 0.5× 277 0.4× 501 1.2× 322 2.0× 24 1.8k
E Madon Italy 19 437 0.5× 321 0.4× 426 0.6× 68 0.2× 234 1.5× 74 1.4k
Giorgio Lambertenghi‐Deliliers Italy 18 429 0.4× 457 0.6× 906 1.3× 88 0.2× 373 2.3× 64 1.5k
Marie Jarošová Czechia 17 301 0.3× 264 0.3× 354 0.5× 84 0.2× 136 0.8× 87 766
Andrey Zaritskey Russia 14 505 0.5× 202 0.3× 429 0.6× 234 0.6× 248 1.5× 66 1.0k
Qin Huang United States 16 263 0.3× 220 0.3× 398 0.6× 73 0.2× 238 1.5× 62 887

Countries citing papers authored by Carles Besses

Since Specialization
Citations

This map shows the geographic impact of Carles Besses's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carles Besses with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carles Besses more than expected).

Fields of papers citing papers by Carles Besses

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carles Besses. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carles Besses. The network helps show where Carles Besses may publish in the future.

Co-authorship network of co-authors of Carles Besses

This figure shows the co-authorship network connecting the top 25 collaborators of Carles Besses. A scholar is included among the top collaborators of Carles Besses based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carles Besses. Carles Besses is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vargas‐Parra, Gardenia, Gemma Navarro, Leonor Arenillas, et al.. (2022). Identification of Two Novel EPOR Gene Variants in Primary Familial Polycythemia: Case Report and Literature Review. Genes. 13(10). 1686–1686. 1 indexed citations
2.
Senín, Alicia, Concepción Fernández‐Rodríguez, Beatríz Bellosillo, et al.. (2017). Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up. Annals of Hematology. 97(3). 443–451. 35 indexed citations
3.
Arboix, Adrià, et al.. (2016). Hematological disorders: a commonly unrecognized cause of acute stroke. Expert Review of Hematology. 9(9). 891–901. 58 indexed citations
4.
Angona, Anna, Alberto Álvarez‐Larrán, Beatríz Bellosillo, et al.. (2014). Trombocitemia esencial: características iniciales y factores de riesgo de supervivencia y trombosis en una serie de 214 pacientes. Medicina Clínica. 144(6). 247–253. 5 indexed citations
5.
Angona, Anna, Beatríz Bellosillo, Alberto Álvarez‐Larrán, et al.. (2013). Genetic predisposition to molecular response in patients with myeloproliferative neoplasms treated with hydroxycarbamide. Leukemia Research. 37(8). 917–921. 25 indexed citations
6.
Hernández‐Boluda, Juan Carlos, Arturo Pereira, Francisco Cervantes, et al.. (2013). Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide. Annals of Hematology. 92(6). 771–775. 25 indexed citations
7.
Gallardo, Miguel, Santiago Barrio, Inmaculada Rapado, et al.. (2011). Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia. Annals of Hematology. 90(8). 939–946. 6 indexed citations
8.
Espinosa, Lluı́s, Séverine Cathelin, Teresa D’Altri, et al.. (2010). The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia. Cancer Cell. 18(3). 268–281. 214 indexed citations
9.
Gimeno, Eva, Blanca Sánchez‐González, Alberto Álvarez‐Larrán, et al.. (2010). Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma. Leukemia Research. 35(3). 358–362. 16 indexed citations
10.
Sánchez‐González, Blanca, M. García García, Sergi Serrano, Carles Besses, & Antonio Salar. (2009). Bendamustine-containing immunochemotherapy is active in transformed follicular lymphoma with overexpression of p53. Leukemia & lymphoma. 50(3). 455–456. 2 indexed citations
11.
Baró, Cristina, Marta Salido, Blanca Espinet, et al.. (2007). New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY). Leukemia Research. 32(5). 727–736. 11 indexed citations
12.
Zamora, Lurdes, Blanca Espinet, Lourdes Florensa, et al.. (2004). Is fluorescence in situ hybridization a useful method in diagnosis of polycythemia vera patients?. Cancer Genetics and Cytogenetics. 151(2). 139–145. 9 indexed citations
13.
Costa, Dolors, Blanca Espinet, Rosa Queralt, et al.. (2003). Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia. Cancer Genetics and Cytogenetics. 141(2). 114–119. 11 indexed citations
14.
Lloveras, Elisabet, Isabel Granada, Lurdes Zamora, et al.. (2003). Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia. Cancer Genetics and Cytogenetics. 148(1). 71–76. 14 indexed citations
15.
Lloveras, Elisabet, Françesc Solé, Lourdes Florensa, et al.. (2002). Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance. Cancer Genetics and Cytogenetics. 132(1). 25–29. 7 indexed citations
16.
Lloveras, Elisabet, Françesc Solé, Blanca Espinet, et al.. (2000). Cytogenetic and Fluorescence In Situ Hybridization Studies in Four Cases of Plasma Cell Leukemia. Cancer Genetics and Cytogenetics. 121(2). 163–166. 1 indexed citations
17.
Solé, Françesc, S Woessner, Lourdes Florensa, et al.. (1999). Cytogenetic Findings in Five Patients with Hairy Cell Leukemia. Cancer Genetics and Cytogenetics. 110(1). 41–43. 7 indexed citations
18.
Espinet, Blanca, Françesc Solé, Francesc Bosch, et al.. (1999). Translocation (11;14)(q13;q32) and Preferential Involvement of Chromosomes 1, 2, 9, 13, and 17 in Mantle Cell Lymphoma. Cancer Genetics and Cytogenetics. 111(1). 92–98. 22 indexed citations
19.
Solé, Françesc, S Woessner, Lourdes Florensa, et al.. (1998). Estudio citogenético en 93 síndromes mielodisplásicos. Medicina Clínica. 110(3). 81–98. 1 indexed citations
20.
Solé, Françesc, Blanca Espinet, Elisabet Lloveras, et al.. (1998). Cytogenetic Abnormalities in Three Patients with B-Cell Prolymphocytic Leukemia. Cancer Genetics and Cytogenetics. 103(1). 43–45. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillermo Garcia‐Manero Breakdown of academic impact, for papers by Alfonso Zaccaria Breakdown of academic impact, for papers by Sybille Albrecht Breakdown of academic impact, for papers by Monica Crugnola Breakdown of academic impact, for papers by Sheng Xiao Breakdown of academic impact, for papers by E Madon Breakdown of academic impact, for papers by Giorgio Lambertenghi‐Deliliers Breakdown of academic impact, for papers by Marie Jarošová Breakdown of academic impact, for papers by Andrey Zaritskey Breakdown of academic impact, for papers by Qin Huang
Rankless by CCL
2026